Insights

More Articles Back to Article

Changing Landscape of Evidence Charting New Assessment Pathways: Q&A with Canadian Agency for Drugs and Technologies in Health (CADTH) CEO Suzanne McGurn

Global Forum discusses the concept of HTA and its place in the therapeutic development of pipeline products—first on a global basis and then within the context of Canadian and other international jurisdictions—with Suzanne McGurn, president and chief executive officer of the Canadian Agency for Drugs and Technologies in Health (CADTH).